scholarly journals Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in Patients with Early Breast Cancer: A Cost-Effectiveness Analysis from the Prospective TOTAM Trial

2022 ◽  
Author(s):  
C. Louwrens Braal ◽  
Anne Kleijburg ◽  
Agnes Jager ◽  
Stijn L. W. Koolen ◽  
Ron H. J. Mathijssen ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cost Effectiveness ◽  
Therapeutic Drug Monitoring ◽  
Early Breast Cancer ◽  
Drug Monitoring ◽  
Cost Effectiveness Analysis ◽  
Adjuvant Tamoxifen ◽  
Therapeutic Drug ◽  
Effectiveness Analysis

Cost-effectiveness analysis of trastuzumab for early breast cancer in Brazil

2021 ◽  
pp. 1-10
Author(s):  
Carlos Henrique Botelho ◽  
Maria Del Pilar Estevez-Diz ◽  
Alessandro Gonçalves Campolina
Keyword(s):  
Breast Cancer ◽  
Cost Effectiveness ◽  
Early Breast Cancer ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis

Updated Cost-Effectiveness Analysis of Trastuzumab for Early Breast Cancer

2011 ◽  
Vol 29 (5) ◽  
pp. 415-432 ◽  
Author(s):  
Peter S. Hall ◽  
Claire Hulme ◽  
Christopher McCabe ◽  
Yemi Oluboyede ◽  
Jeff Round ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cost Effectiveness ◽  
Early Breast Cancer ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis

scholarly journals PCN7 COST-EFFECTIVENESS ANALYSIS OF ADJUVANT THERAPY WITH TRASTUZUMAB FOR HER2-POSITIVE EARLY BREAST CANCER IN POLISH SETTING

2007 ◽  
Vol 10 (3) ◽  
pp. A125 ◽  
Author(s):  
E Orlewska ◽  
T Pienkowski ◽  
K Drosik ◽  
M Gyldmark ◽  
R Aultman ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cost Effectiveness ◽  
Adjuvant Therapy ◽  
Early Breast Cancer ◽  
Cost Effectiveness Analysis ◽  
Her2 Positive ◽  
Effectiveness Analysis
Sign in / Sign up

Export Citation Format

Share Document